Does BIFIDOBACTERIUM LONGUM Cause Hepatotoxicity? 31 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hepatotoxicity have been filed in association with BIFIDOBACTERIUM LONGUM. This represents 22.1% of all adverse event reports for BIFIDOBACTERIUM LONGUM.
31
Reports of Hepatotoxicity with BIFIDOBACTERIUM LONGUM
22.1%
of all BIFIDOBACTERIUM LONGUM reports
0
Deaths
28
Hospitalizations
How Dangerous Is Hepatotoxicity From BIFIDOBACTERIUM LONGUM?
Of the 31 reports, 28 (90.3%) required hospitalization.
Is Hepatotoxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM Cause?
Off label use (93)
Abdominal pain (58)
Malaise (58)
Anaemia (57)
Chronic sinusitis (57)
Colitis (57)
Constipation (57)
Drug ineffective (57)
Erythema (57)
Female genital tract fistula (57)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which BIFIDOBACTERIUM LONGUM Alternatives Have Lower Hepatotoxicity Risk?
BIFIDOBACTERIUM LONGUM vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BIFIDOBACTERIUM LONGUM vs BILASTINE
BIFIDOBACTERIUM LONGUM vs BIMATOPROST
BIFIDOBACTERIUM LONGUM vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM vs BIMEKIZUMAB